Record 037 · Therapeutics · 2021
50%21.37.X
YouthBio Therapeutics
YouthBio Therapeutics
“Partial reprogramming gene therapy for tissues that age in public.”
YouthBio develops inducible OSK-style gene therapies aimed at Alzheimer’s and broader aging. A gene-therapy vehicle for the Yamanaka idea.
Reprogramming that has to ship as a vector.
Pre-seed & seed. Filed from the Top Tier Impact landscape.
- Inducible reprogramming
- CNS target
Reprogram a tissue.
